We are live on ! Find out more
PVI

Pura Vida Investments Portfolio holdings

AUM $14.9M
1-Year Est. Return 38.76%
This Fund
S&P 500
This Quarter Est. Return
+17.46%
1 Year Est. Return
+38.76%
3 Year Est. Return
+26.8%
5 Year Est. Return
+25.03%
10 Year Est. Return
+1,723.84%
AUM
$1.94B
AUM Growth
+$209M
Cap. Flow
+$157M
Cap. Flow %
8.08%
Top 10 Hldgs %
37.79%
Holding
268
New
72
Increased
34
Reduced
55
Closed
76

Top Buys

Rank Stock Value
1
BIIB icon
Biogen
BIIB
+$16.3M
2
SONX
Sonendo, Inc.
SONX
+$7.34M
3
NTRA icon
Natera
NTRA
+$6.8M
4
AZTA icon
Azenta
AZTA
+$6.45M
5
QTRX icon
Quanterix
QTRX
+$5.89M

Top Sells

Rank Stock Value
1
UTHR icon
United Therapeutics
UTHR
+$22.4M
2
ILMN icon
Illumina
ILMN
+$11.7M
3
AZN icon
AstraZeneca
AZN
+$9.6M
4
OM icon
Outset Medical
OM
+$8.46M
5
VRTX icon
Vertex Pharmaceuticals
VRTX
+$7.3M

Sector Composition

Rank Sector Weight
1 Healthcare 27.35%
2 Industrials 0.25%
3 Materials 0%
Name Market Value Portfolio Weight Shares or Principal Change
in Stake 		Capital Flow
SPY icon
1
PUT
State Street SPDR S&P 500 ETF Trust
SPY
$823B
$111M 5.72%
290,000
+165,000
+132% +$63.4M
QQQ icon
2
PUT
Invesco QQQ Trust
QQQ
$484B
$108M 5.57%
405,000
+280,000
+224% +$77.4M
OEF icon
3
PUT
iShares S&P 100 ETF
OEF
$20.6B
$95.9M 4.95%
550,000
-50,000
-8% -$8.63M
ILCV icon
4
PUT
iShares Morningstar Value ETF
ILCV
$1.35B
$78.9M 4.07%
1,500,000
+500,000
+50% +$31.2M
FXD icon
5
PUT
First Trust Consumer Discretionary AlphaDEX Fund
FXD
$276M
$76.1M 3.93%
700,000
+200,000
+40% +$9.6M
ESTA icon
6
Establishment Labs
ESTA
$2.28B
$62.5M 3.23%
952,767
-3,978
-0.4% -$240K
VRAY
7
DELISTED
ViewRay, Inc.
VRAY
$56.2M 2.9%
12,549,009
-1,115,930
-8% -$4.85M
INSP icon
8
Inspire Medical Systems
INSP
$1.74B
$50.6M 2.61%
200,984
-600
-0.3% -$128K
XNTK icon
9
PUT
State Street SPDR NYSE Technology ETF
XNTK
$2.23B
$47.3M 2.44%
570,000
-30,000
-5% -$2.97M
BAX icon
10
CALL
Baxter International
BAX
$14.2B
$45.9M 2.37%
900,000
+699,300
+348% +$37.6M
CUTR
11
DELISTED
Cutera, Inc.
CUTR
$45.8M 2.36%
1,036,021
+17,402
+2% +$793K
ARKK icon
12
PUT
ARK Innovation ETF
ARKK
$6.31B
$38.3M 1.97%
1,225,000
+775,000
+172% +$27.7M
GKOS icon
13
Glaukos
GKOS
$10.6B
$33.2M 1.72%
761,049
+56,637
+8% +$2.79M
UNH icon
14
PUT
UnitedHealth
UNH
$370B
$31.8M 1.64%
60,000
– –
GDX icon
15
PUT
VanEck Gold Miners ETF
GDX
$27.4B
$31.1M 1.6%
400,000
– –
XLV icon
16
PUT
State Street Health Care Select Sector SPDR ETF
XLV
$42.7B
$29.9M 1.54%
+220,000
New +$29.2M
ISRG icon
17
CALL
Intuitive Surgical
ISRG
$134B
$29.2M 1.51%
110,000
+15,000
+16% +$3.66M
BIIB icon
18
CALL
Biogen
BIIB
$30.7B
$28.6M 1.48%
103,400
-119,600
-54% -$33.8M
SRPT icon
19
CALL
Sarepta Therapeutics
SRPT
$1.77B
$25.9M 1.34%
200,000
– –
ARKG icon
20
PUT
ARK Genomic Revolution ETF
ARKG
$1.73B
$25.4M 1.31%
900,000
+400,000
+80% +$12.7M
ISEE
21
DELISTED
IVERIC bio, Inc. Common Stock
ISEE
$25.3M 1.31%
1,182,975
+207,545
+21% +$4.43M
TMO icon
22
PUT
Thermo Fisher Scientific
TMO
$220B
$22M 1.14%
+40,000
New +$21.2M
SYK icon
23
PUT
Stryker
SYK
$130B
$22M 1.14%
90,000
+45,000
+100% +$10.2M
STAA icon
24
PUT
STAAR Surgical
STAA
$1.21B
$20.6M 1.06%
425,000
+55,000
+15% +$3.45M
NVCR icon
25
PUT
NovoCure
NVCR
$1.91B
$19.4M 1%
265,100
+120,000
+83% +$9.03M
1
2 3 4 5

Similar funds

BCA
Boundary Creek Advisors New York $15.3M AUM 0.41% 1-Year Est. Return
ONGA
O'Neil Global Advisors Los Angeles, California $14.4M AUM 220.73% 1-Year Est. Return
RC
Raine Capital New York $14.1M AUM 33.16% 1-Year Est. Return
DOFI
DCVC Opportunity Fund II Palo Alto, California $13.9M AUM 8.04% 1-Year Est. Return
SR
Swiss Re Zurich, Switzerland $16.4M AUM
SCI
SkyBridge Capital II New York $13.1M AUM 3.36% 1-Year Est. Return
LPC
Lion Point Capital New York $16.7M AUM 119.35% 1-Year Est. Return
GBCP
Glade Brook Capital Partners Greenwich, Connecticut $12.8M AUM

Pura Vida Investments's Q4 2022 Portfolio in Review

As of Q4 2022, Pura Vida Investments held 268 positions worth $1.94B, up 12% from $1.73B the previous quarter. Its ten largest holdings account for 38% of the portfolio.

Pura Vida Investments deployed $157M of net new capital in Q4 2022, opening 72 new positions and adding to 34 existing holdings. Its largest new stake was Natera: 165,000 shares worth $6.63M.

By sector, the portfolio is most concentrated in Healthcare at 27% of assets, down from 35% a quarter earlier, followed by Industrials and Materials.

On the sell side, the largest reduction was United Therapeutics, an estimated $22.4M trimmed.

  • Pura Vida Investments's largest Q4 2022 buy was Natera: 165,000 shares worth $6.63M.
  • Pura Vida Investments added most to Biogen in Q4 2022, an estimated $16.3M increase.
  • Pura Vida Investments's biggest Q4 2022 reduction was United Therapeutics, cutting an estimated $22.4M.
  • Pura Vida Investments fully exited Illumina in Q4 2022, selling an estimated $11.7M.
  • Pura Vida Investments's ten largest holdings make up 38% of its $1.94B portfolio in Q4 2022.
  • Pura Vida Investments opened 72 new positions and closed 76 in Q4 2022.
  • Pura Vida Investments's portfolio value rose 12% quarter-over-quarter to $1.94B.

Based on Pura Vida Investments's 13F filing for Q4 2022, filed 14 Feb 2023.